Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK.

PURPOSE To compare the efficacy of two topical nonsteroidal anti-inflammatory drugs with regards to the control of pain, burning, photophobia, foreign body sensation, and epithelial healing rates in patients who underwent photorefractive keratectomy (PRK). METHODS Two hundred twelve eyes were randomized to receive topical postoperative ketorolac 0.4% four times daily (Acular LS, Allergan) or bromfenac 0.09% twice daily (Xibrom, ISTA Pharmaceuticals) in an open label trial. Patients having both eyes treated received ketorolac in one eye and bromfenac in the other. The epithelium was removed using the 8.4-mm Amoils brush (Innovative Excimer Solutions), and various laser beam platforms were permitted for the surgery. Investigated drugs were applied after a bandage contact lens (Acuvue Oasys, Johnson & Johnson Vision Care) was fitted. All patients received postoperative cold saline (balanced saline solution [BSS]), prednisolone acetate 1.0% (Pred Forte, Allergan), gatifloxacin ophthalmic solution 0.3% (Zymar, Allergan), and in some cases, mitomycin C 0.02% (MMC). Patients recorded postoperative results for pain, photophobia, burning, and foreign-body sensation on a visual linear analog scale. During postoperative follow-up, the corneal epithelial defect was measured. RESULTS Two hundred twelve eyes from 149 patients were enrolled in the study. Of these eyes, 105 received bromfenac and 107 received ketorolac. No significant differences were noted in postoperative pain, burning, foreign-body sensation, and photophobia between the two drug populations at any time during the study or overall. There were no drug-related adverse events or differences in epithelial healing rates for either drug. CONCLUSIONS No significant differences were observed between the use of bromfenac (twice daily) and ketorolac (four times daily) with regard to postoperative PRK discomfort and safety when combined with postoperative measures such as cold BSS and a bandage contact lens.

[1]  M. Raizman,et al.  Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. , 2008, Cornea.

[2]  C. Kirwan,et al.  Postoperative pain following epi-LASIK, LASEK, and PRK for myopia. , 2006, Journal of refractive surgery.

[3]  E. Donnenfeld,et al.  Global Experience With Xibrom (Bromfenac Ophthalmic Solution) 0.09%: The First Twice-daily Ophthalmic Nonsteroidal Anti-inflammatory Drug , 2006, International ophthalmology clinics.

[4]  M. Raizman,et al.  Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post‐photorefractive keratectomy patients , 2004, Journal of cataract and refractive surgery.

[5]  Suzanne G McLennan,et al.  Ocular surface management of photorefractive keratectomy and laser in situ keratomileusis. , 2003, Journal of refractive surgery.

[6]  Timo Tervo,et al.  In vivo confocal microscopy for evaluation of wound healing following corneal refractive surgery , 2003, Progress in Retinal and Eye Research.

[7]  M. Lui,et al.  Complications of photorefractive keratectomy and laser in situ keratomileusis. , 2003, Journal of refractive surgery.

[8]  H. Mishima,et al.  [Evaluation and multivariate statistical analysis of factors influencing patient adherence to ophthalmic solutions]. , 2001, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[9]  M. Vetrugno,et al.  A randomized, double-masked, clinical study of the efficacy of four nonsteroidal anti-inflammatory drugs in pain control after excimer laser photorefractive keratectomy. , 2000, Clinical therapeutics.

[10]  J. Arne,et al.  A prospective randomized trial of topical soluble 0.1% indomethacin versus 0.1% diclofenac versus placebo for the control of pain following excimer laser photorefractive keratectomy. , 1998, Ophthalmic surgery and lasers.

[11]  S. Shah,et al.  Efficacy of topical nonsteroidal drops as pain relief after excimer laser photorefractive keratectomy. , 1998, Journal of refractive surgery.

[12]  D. Azar,et al.  A prospective evaluation of alcohol-assisted versus mechanical epithelial removal before photorefractive keratectomy. , 1997, Ophthalmology.

[13]  S. Jain,et al.  Dilute topical proparacaine for pain relief after photorefractive keratectomy. , 1997, Ophthalmology.

[14]  T. Tokoro,et al.  The efficacy of cooling on excimer laser photorefractive keratectomy in the rabbit eye. , 1997, Survey of ophthalmology.

[15]  J. Abad,et al.  Dilute ethanol versus mechanical debridement before photorefractive keratectomy , 1996, Journal of cataract and refractive surgery.

[16]  Weinstock Sj,et al.  Diclofenac and ketorolac in the treatment of pain after photorefractive keratectomy. , 1996 .

[17]  M. Fsadni,et al.  Efficacy and safety of topical diclofenac in reducing ocular pain after excimer photorefractive keratectomy , 1996, Journal of cataract and refractive surgery.

[18]  J. Marshall,et al.  A prospective, randomized, double-masked trial to evaluate the role of topical anesthetics in controlling pain after photorefractive keratectomy. , 1995, Ophthalmology.

[19]  S. Lane,et al.  Topical diclofenac in the treatment of ocular pain after excimer photorefractive keratectomy. , 1993, Refractive & corneal surgery.